Gregory Roth on Muck Rack

Gregory Roth

New York
As seen in: Nature, MDPI, JAMA (The Journal of the American Medical Association), Cell Press, Dialnet - Universidad de La Rioja, Institute for Health Metrics and Evaluation (IHME), JACC (Journal of the American College of Cardiology), Farms.com, AgFax, Landscape Photography Magazine
Director of Communications @EurasiaGroup and @GZEROMedia. Previously, reporter/editor/producer at WSJ, NYT, Reuters & CNBC
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Gregory

Contact Gregory, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Why is my measurement different from your?

|
By Gregory Roth
| Dialnet - Universidad de La Rioja
Ayuda Buscar en la ayuda Buscar en la ayuda
Open in Who Shared View Duplicates (700) Issue with article?

Enhancer control of promoter activity and variability via frequency modulation of clustered transcriptional bursts

|
By Gregory Roth, Julie Cramard, Luca Giorgetti
| biorxiv.org
Abstract Gene expression in mammalian cells is controlled by enhancers that are often dispersed across large cis-regulatory landscapes around a promoter. Yet how enhancers determine transcription of their target genes, and how this depends on their relative position inside a cis-regulatory landscape remains unclear.
Open in Who Shared Issue with article?

TORC2 inhibition triggers yeast chromosome fragmentation through misregulated Base Excision Repair of clustered oxidation events - Nature Communications

|
By Kenji Shimada, Gregory Roth, Verena Hurst, Christian B. Gerhold, Barbara van Loon, Stephen B. Helliwell
| Nature Verified
Abstract Combinational therapies provoking cell death are of major interest in oncology. Combining TORC2 kinase inhibition with the radiomimetic drug Zeocin results in a rapid accumulation of double-strand breaks (DSB) in the budding yeast genome. This lethal Yeast Chromosome Shattering (YCS) requires conserved enzymes of base excision repair.
Open in Who Shared Issue with article?
See all 12 licensed articles (14 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified